Package 71610-839-30

{"route": ["ORAL"], "spl_id": "1a8a808c-982f-49a8-e063-6294a90aa348", "openfda": {"unii": ["WY6W63843K"], "rxcui": ["854894"], "spl_set_id": ["1a8a8072-39bf-44c5-e063-6294a90a77c3"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-839-30)", "package_ndc": "71610-839-30", "marketing_start_date": "20240604"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-839-53)", "package_ndc": "71610-839-53", "marketing_start_date": "20240604"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-839-60)", "package_ndc": "71610-839-60", "marketing_start_date": "20240604"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-839-80)", "package_ndc": "71610-839-80", "marketing_start_date": "20240604"}], "brand_name": "ZOLPIDEM TARTRATE", "product_id": "71610-839_1a8a808c-982f-49a8-e063-6294a90aa348", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Receptor Positive Modulators [MoA]", "gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"], "product_ndc": "71610-839", "dea_schedule": "CIV", "generic_name": "Zolpidem Tartrate", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZOLPIDEM TARTRATE", "active_ingredients": [{"name": "ZOLPIDEM TARTRATE", "strength": "6.25 mg/1"}], "application_number": "ANDA078970", "marketing_category": "ANDA", "marketing_start_date": "20140411", "listing_expiration_date": "20261231"}